Literature DB >> 17547684

Impact of the Y-containing cell line on histological differentiation patterns in dysgenetic gonads.

Martine Cools1, Marjan Boter, Ruud van Gurp, Hans Stoop, Pino Poddighe, Yun-Fai Chris Lau, Stenvert L S Drop, Katja P Wolffenbuttel, Leendert H J Looijenga.   

Abstract

OBJECTIVE: Gonadal karyotyping is considered a tool for increasing our knowledge of disturbed gonadal development in patients with gonadal dysgenesis and for estimating more accurately the risk for gonadoblastoma formation. The objective was to gain insight into the role of Y chromosome distribution in the histological heterogeneity of gonads of patients with gonadal dysgenesis.
DESIGN: Investigation of the possible relationship between peripheral blood karyotype, gonadal karyotype, morphological differentiation patterns of dysgenetic gonads and tumour formation. PATIENTS: In total 22 gonadal samples from 19 patients with gonadal dysgenesis (45,X/46,XY and variants n = 14; 46,XY: n = 3; 46,XX: n = 2) were examined. MEASUREMENTS: Morphological examination and immunohistochemical staining for testis specific protein, Y encoded (TSPY) and fluorescent and nonfluorescent in situ hybridization directly on gonadal tissue.
RESULTS: No correlation was observed between peripheral blood karyotype and gonadal karyotype or between gonadal karyotype and the corresponding differentiation pattern. A Y-containing cell line in Sertoli cells was encountered no more frequently than were other cell types.
CONCLUSIONS: The distribution of the Y-containing cell line in peripheral blood is not a suitable indicator for predicting the histological differentiation pattern found in the gonads of patients with gonadal dysgenesis. The analysis of Y-containing cell lines in the gonads of such patients could be informative with regard to the specific characteristics of gonadal development in humans as compared to chimeric mouse models. Moreover, it is essential to understand the mechanisms underlying disturbed gonadogenesis in these patients. As the gonadal karyotype is not related to the encountered gonadal differentiation pattern, it does not allow prediction of the risk for gonadoblastoma formation.

Entities:  

Mesh:

Year:  2007        PMID: 17547684     DOI: 10.1111/j.1365-2265.2007.02859.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

1.  Clinical and Reproductive Characteristics of Patients with Mixed Gonadal Dysgenesis (45,X/46, XY).

Authors:  Darvin V Das; P K Jabbar
Journal:  J Obstet Gynaecol India       Date:  2021-03-05

2.  Serum Concentrations and Gonadal Expression of INSL3 in Eighteen Males With 45,X/46,XY Mosaicism.

Authors:  Marie Lindhardt Ljubicic; Anne Jørgensen; Lise Aksglaede; John Erik Nielsen; Jakob Albrethsen; Anders Juul; Trine Holm Johannsen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-10       Impact factor: 5.555

3.  Mediastinal germ cell tumors: many questions and perhaps an answer.

Authors:  J Wolter Oosterhuis; Leendert Hj Looijenga
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

4.  Clinical characteristics, cytogenetic and molecular findings in patients with disorders of sex development.

Authors:  Li Tian; Ming Chen; Jian-Hong Peng; Jian-Wu Zhang; Li Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-02-06

5.  Identification of X monosomy cells from a gonad of mixed gonadal dysgenesis with a 46,XY karyotype: case report.

Authors:  Noriko Nishina-Uchida; Ryuji Fukuzawa; Yukihiro Hasegawa; Ian M Morison
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

6.  Multidisciplinary Approach to the Child with Sex Chromosomal Mosaicism Including a Y-Containing Cell Line.

Authors:  Bauke Debo; Marlies Van Loocke; Katya De Groote; Els De Leenheer; Martine Cools
Journal:  Int J Environ Res Public Health       Date:  2021-01-21       Impact factor: 3.390

7.  SRY mutation analysis by next generation (deep) sequencing in a cohort of chromosomal Disorders of Sex Development (DSD) patients with a mosaic karyotype.

Authors:  Remko Hersmus; Hans Stoop; Erin Turbitt; J Wolter Oosterhuis; Stenvert Ls Drop; Andrew H Sinclair; Stefan J White; Leendert Hj Looijenga
Journal:  BMC Med Genet       Date:  2012-11-16       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.